These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 200987)

  • 1. [Comparison between two types of pertussis vaccines].
    Bisaillon JG
    Rev Can Biol; 1977 Sep; 36(3):283-9. PubMed ID: 200987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene-expression-based quality scores indicate optimal harvest point in Bordetella pertussis cultivation for vaccine production.
    van de Waterbeemd B; Streefland M; Pennings J; van der Pol L; Beuvery C; Tramper J; Martens D
    Biotechnol Bioeng; 2009 Aug; 103(5):900-8. PubMed ID: 19405154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on culture conditions of Bordetella pertussis and relationship to immunogenicity of vaccines.
    Bellalou J; Relyveld EH
    Ann Microbiol (Paris); 1984; 135B(1):101-10. PubMed ID: 6095715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pertussis vaccine--fact and fiction.
    Cameron J; Stainer DW
    Acta Microbiol Acad Sci Hung; 1977; 24(3):195-205. PubMed ID: 203169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of relevant culture parameters on Pertussis Toxin expression by Bordetella pertussis.
    Thalen M; Venema M; van den IJssel J; Berwald L; Beuvery C; Martens D; Tramper J
    Biologicals; 2006 Sep; 34(3):213-20. PubMed ID: 16497513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between optical density and viable germ count during cultivation of B. pertussis.
    Csizér Z; Pusztai Z; Joó I
    Zentralbl Bakteriol Orig; 1971; 216(2):215-8. PubMed ID: 4325114
    [No Abstract]   [Full Text] [Related]  

  • 7. [Optimization of the pertussis vaccine production process].
    Germán Santiago J; Zamora N; de la Rosa E; Alba Carrión C; Padrón P; Hernández M; Betancourt M; Moretti N
    Acta Cient Venez; 1995; 46(2):129-34. PubMed ID: 9279028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of the potency of the pertussis component in DPT vaccine produced in stationary culture and by fermentation].
    Galicia O; Villalva H; Pérez A; Pérez S; Medina A
    Salud Publica Mex; 1981; 23(6):607-11. PubMed ID: 6278658
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization and clinical study on the acellular pertussis vaccine produced by a combination of column purified pertussis toxin and filamentous hemagglutinin.
    Ginnaga A; Morokuma K; Aihara K; Sakou M; Imaizumi A; Suzuki Y; Sato H; Sato Y; Ueda K; Kuno-Sakai H
    Tokai J Exp Clin Med; 1988; 13 Suppl():59-69. PubMed ID: 2908528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of surface antigens in the protective potency of Bordetella pertussis suspensions as measured by the intracerebral challenge technique in mice.
    Holt LB; Spasojevíc V
    J Med Microbiol; 1968 Aug; 1(1):119-26. PubMed ID: 4318938
    [No Abstract]   [Full Text] [Related]  

  • 11. Acetone-treated pertussis vaccine--a potent and safer new pertussis vaccine.
    Saran G
    J Biol Stand; 1985 Oct; 13(4):315-20. PubMed ID: 4055808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of a Bordetella pertussis patient isolated strain and classical strains used in the pertussis vaccine.
    Pereira A; Pereira AS; Moreira-Filho CA; Bando SY; Tambourgi DV
    Vaccine; 2005 Jul; 23(34):4353-8. PubMed ID: 16005744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bordetella pertussis serotypes in Canada.
    Toma S; Lo H; Magus M
    Can Med Assoc J; 1978 Oct; 119(7):722-4. PubMed ID: 213182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collaborative study for the standardisation of the histamine sensitizing test in mice and the CHO cell-based assay for the residual toxicity testing of acellular pertussis vaccines.
    Xing D; Maes A; Behr-Gross ME; Costanzo A; Daas A; Buchheit KH
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):51-63. PubMed ID: 20223190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory Maintenance of Bordetella pertussis.
    Hulbert RR; Cotter PA
    Curr Protoc Microbiol; 2009 Nov; Chapter 4():Unit 4B.1. PubMed ID: 19885941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Charcoal agar culture medium for preparing Hemophilus pertussis vaccine.
    POWELL HM; CULBERTSON CG; ENSMINGER PW
    Public Health Rep (1896); 1951 Mar; 66(11):346-8. PubMed ID: 14816499
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlation between growth rate and loss of histamine-sensitizing factor during antigenic modulation in Bordetella pertussis.
    Idigbe EO
    Microbios; 1987; 49(199):79-89. PubMed ID: 2883559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of vaccines against Bordetella parapertussis in a mouse intranasal challenge model.
    Komatsu E; Yamaguchi F; Eguchi M; Watanabe M
    Vaccine; 2010 Jun; 28(27):4362-8. PubMed ID: 20438876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acellular anti-pertussis vaccine].
    Bégué P; Grimpel E; Baron S
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):859-65. PubMed ID: 1819434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Restriction analysis of Bordetella pertussis DNA isolated from patients with whooping cough in 1968 and 1995-98 and B. pertussis used for production of national vaccine strains].
    Chodorowska M; Kuklińska D
    Med Dosw Mikrobiol; 2000; 52(2):111-7. PubMed ID: 11107785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.